Copyright
©The Author(s) 2022.
World J Gastrointest Surg. Sep 27, 2022; 14(9): 950-962
Published online Sep 27, 2022. doi: 10.4240/wjgs.v14.i9.950
Published online Sep 27, 2022. doi: 10.4240/wjgs.v14.i9.950
Table 1 Clinical and pathological characteristics of laparoscopic assisted gastrectomy and totally laparoscopic gastrectomy group for elderly patients (mean ± SD)
Characteristics | LAG group (n = 232) | TLG group (n = 230) | P value |
Gender | 0.472 | ||
Male | 183 | 175 | |
Female | 49 | 55 | |
Age (yr) | 74.62 ± 3.80 | 74.69 ± 4.10 | 0.848 |
BMI (kg/m2) | 23.31 ± 3.08 | 23.64 ± 3.46 | 0.285 |
aCCI score, n (%) | 0.608 | ||
0-4 | 188 | 182 | |
> 4 | 44 | 48 | |
ASA score, n (%) | 0.426 | ||
I | 1 | 1 | |
II | 177 | 168 | |
III | 54 | 61 | |
History of abdominal surgery | 0.232 | ||
No | 189 | 177 | |
Yes | 43 | 53 | |
Tumor resection | 0.163 | ||
Distal | 125 | 109 | |
Total | 107 | 121 | |
Neoadjuvant chemotherapy | 0.201 | ||
No | 223 | 215 | |
Yes | 9 | 15 | |
Tumor diameters (cm) (median, IQR) | 4.00 (2.58-6.00) | 4.00 (2.65-5.5) | 0.230 |
pT | 0.895 | ||
T0 | 2 | 0 | |
T1 | 38 | 43 | |
T2 | 36 | 37 | |
T3 | 116 | 107 | |
T4 | 40 | 43 | |
pN | 0.544 | ||
N0 | 83 | 77 | |
N1 | 33 | 33 | |
N2 | 49 | 48 | |
N3 | 67 | 72 | |
pTNM | 0.857 | ||
0 | 2 | 0 | |
I | 52 | 60 | |
II | 65 | 57 | |
III | 113 | 113 | |
Nerve invasion | 0.249 | ||
Yes | 71 | 82 | |
No | 161 | 148 | |
Vascular invasion | 0.685 | ||
Yes | 91 | 86 | |
No | 141 | 144 | |
Differentiation | 0.945 | ||
Well/moderate | 151 | 149 | |
Poor/undifferentiated | 81 | 81 |
Table 2 Perioperative outcomes between laparoscopic assisted gastrectomy and totally laparoscopic gastrectomy group for elderly patients (mean ± SD)
Variable | LAG group (n = 232) | TLG group (n = 230) | P value |
Surgical time, min | 221.34 ± 54.96 | 216.48 ± 52.53 | 0.332 |
Blood loss, ml (median, IQR) | 100.0 (50.0-200.0) | 100.0 (50.0-100.0) | 0.000 |
Anastomotic approach | |||
B1 | 17 | 14 | |
B2 (+Braun) | 39 | 36 | |
Roux-en-Y | 176 | 180 | |
Retrieved lymph nodes, n | 29.32 ± 11.27 | 30.69 ± 12.65 | 0.218 |
Extent of resection | |||
R0 | 218 | 215 | |
R1/R2 | 14 | 15 | |
Time to first flatus, d | 4.43 ± 1.20 | 3.79 ± 1.15 | 0.000 |
Postoperative day, d (median, IQR) | 8.0 (7.0-10.0) | 7.75 (6.0-9.0) | 0.000 |
Total complication rate (%) | 61 (26.3) | 38 (16.5) | 0.010 |
Anastomotic-related complication rate (%) | 8 (3.4) | 6 (2.6) | 0.599 |
Clavien-Dindo classification | |||
Grade II | |||
Deep venous thrombosis | 1 | 1 | |
Lymphatic leakage | 1 | 0 | |
Gastroplegia | 1 | 2 | |
Anaphylaxis | 1 | 1 | |
Ileus | 0 | 1 | |
Cardiac failure | 1 | 0 | |
Hypoproteinemia | 10 | 7 | |
Anemia | 12 | 7 | |
Cholecystitis | 2 | 0 | |
Incision infection | 2 | 1 | |
Atrial fibrillation | 4 | 2 | |
Pneumonia | 8 | 2 | |
Anastomotic leakage | 5 | 2 | |
Anastomotic bleeding | 0 | 2 | |
Anastomotic stenosis | 1 | 0 | |
Duodenal trump leakage | 2 | 1 | |
Grade IIIa | |||
Deep venous thrombosis | 0 | 0 | |
Pleural effusion | 4 | 3 | |
Anastomotic leakage | 2 | 2 | |
Duodenal trump leakage | 1 | 1 | |
Abdominal bleeding | 0 | 1 | |
Grade IV | |||
Cardiac failure | 2 | 0 | |
Abdominal bleeding | 1 | 1 | |
Acute cerebral infarction | 0 | 1 | |
Severe complication rate (%) | 10 (4.3) | 9 (3.9) | 0.830 |
Table 3 Uni- and multivariate analysis of postoperative complications for elderly patients
Factor | Univariate analysis | P value | Multivariate analysis | P value | ||
OR | 95%CI | OR | 95%CI | |||
Sex | 0.462 | |||||
Male | 1.000 | |||||
Female | 1.215 | 0.724-2.038 | ||||
Age (yr) | 0.027 | 0.157 | ||||
< 75 | 1.000 | 1.000 | ||||
≥ 75 | 1.655 | 1.058-2.587 | 1.422 | 0.874-2.313 | ||
BMI (kg/m2) | 0.321 | |||||
< 25 | 1.000 | |||||
≥ 25 | 0.779 | 0.475-1.276 | ||||
Surgical approach | 0.011 | 0.011 | ||||
LAG | 1.000 | 1.000 | ||||
TLG | 0.555 | 0.352-0.874 | 0.539 | 0.335-0.865 | ||
aCCI score | 0.074 | 0.416 | ||||
0-4 | 1.000 | 1.000 | ||||
> 4 | 1.603 | 0.952-2.699 | 1.276 | 0.709-2.294 | ||
ASA score | 0.030 | 0.069 | ||||
≤ II | 1.000 | 1.000 | ||||
> II | 1.713 | 1.055-2.783 | 1.626 | 0.963-2.744 | ||
Tumor resection | 0.846 | |||||
Distal | 1.000 | |||||
Total | 0.957 | 0.613-1.493 | ||||
Neoadjuvant chemotherapy | 0.752 | |||||
No | 1.000 | |||||
Yes | 1.165 | 0.452-3.000 | ||||
pTNM stage | 0.918 | |||||
0-I | 1.000 | |||||
II | 1.072 | 0.571-2.012 | ||||
III | 1.124 | 0.645-1.958 | ||||
Tumor diameter (cm) | 0.020 | 0.116 | ||||
≤ 3 | 1.000 | 1.000 | ||||
> 3 | 1.815 | 1.101-2.995 | 1.535 | 0.900-2.618 | ||
Operation time (min) | 0.031 | 0.039 | ||||
≤ 220 | 1.000 | 1.000 | ||||
> 220 | 1.636 | 1.047-2.558 | 1.671 | 1.027-2.718 | ||
Estimated blood loss (mL) | 0.120 | 0.895 | ||||
≤ 200 | 1.000 | 1.000 | ||||
> 200 | 1.628 | 0.880-3.012 | 1.047 | 0.530-2.070 | ||
Vascular invasion | 0.035 | 0.223 | ||||
No | 1.000 | 1.000 | ||||
Yes | 1.620 | 1.034-2.538 | 1.349 | 0.834-2.185 | ||
Nerve invasion | 0.667 | |||||
No | 1.000 | |||||
Yes | 0.901 | 0.559-1.451 | ||||
Differentiation | 0.760 | |||||
Well/moderate | 1.000 | |||||
Poor/undifferentiated | 1.075 | 0.676-1.708 | ||||
R0 resection | 0.197 | 0.263 | ||||
No | 1.000 | 1.000 | ||||
Yes | 1.715 | 0.755-3.895 | 1.639 | 0.690-3.892 |
Table 4 Quality of life using European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire and STO-22 questionnaire between laparoscopic assisted gastrectomy and totally laparoscopic gastrectomy group
Factor | Baseline | P value | Postoperative 3 mo | P value | ||
LAG group | TLG group | LAG group | TLG group | |||
QLQ-C30 questionnaire | ||||||
Global status | 91.6 (91.6-100) | 91.6 (91.6-100) | 0.096 | 91.6 (91.6-100) | 91.6 (91.6-100) | 0.934 |
Physical functioning | 100 (93.3-100) | 100 (93.3-100) | 0.863 | 100 (93.3-100) | 96.7(93.3-100) | 0.777 |
Role functioning | 100 (83.3-100) | 100 (83.3-100) | 0.269 | 100 (83.3-100) | 83.3 (83.3-100) | 0.804 |
Emotional functioning | 91.6 (91.6-100) | 91.6 (91.6-100) | 0.343 | 91.6 (91.6-100) | 91.6 (91.6-100) | 0.880 |
Cognitive functioning | 100 (83.3-100) | 100 (83.3-100) | 0.962 | 100 (83.3-100) | 100 (83.3-100) | 0.925 |
Social functioning | 100 (83.3-100) | 100 (83.3-100) | 0.853 | 100 (83.3-100) | 100 (83.3-100) | 0.925 |
Fatigue | 0 (0-0) | 0 (0-0) | 0.471 | 0 (0-0) | 0 (0-11) | 0.170 |
Nausea and vomiting | 0 (0-0) | 0 (0-0) | 0.133 | 0 (0-12.5) | 0 (0-0) | 0.043 |
Pain | 0 (0-0) | 0 (0-0) | 0.507 | 0 (0-0) | 0 (0-0) | 0.772 |
Dyspnea | 0 (0-0) | 0 (0-0) | 0.165 | 0 (0-0) | 0 (0-0) | 0.880 |
Insomnia | 0 (0-33.3) | 0 (0-33.3) | 0.428 | 0 (0-33.3) | 0 (0-33.3) | 0.984 |
Appetite loss | 0 (0-0) | 0 (0-33.3) | 0.494 | 0 (0-33.3) | 0 (0-33.3) | 0.899 |
Constipation | 0 (0-33.3) | 0 (0-33.3) | 0.529 | 33.3 (0-33.3) | 0 (0-33.3) | 0.024 |
Diarrhea | 0 (0-0) | 0 (0-0) | 0.122 | 0 (0-0) | 0 (0-0) | 0.705 |
Financial difficulties | 0 (0-33.3) | 0 (0-33.3) | 0.081 | 0 (0-33.3) | 0 (0-33.3) | 0.355 |
STO-22 questionnaire | ||||||
Dysphagia | 0 (0-0) | 0 (0-0) | 0.547 | 0 (0-22) | 0 (0-11) | 0.169 |
Pain | 0 (0-0) | 0 (0-0) | 0.793 | 0 (0-14.6) | 0 (0-8.3) | 0.389 |
Reflux | 0 (0-11) | 0 (0-11) | 0.444 | 0 (0-22) | 0 (0-22) | 0.548 |
Eating restrictions | 0 (0-0) | 0 (0-0) | 0.441 | 0 (0-8.3) | 0 (0-8.3) | 0.848 |
Anxiety | 0 (0-11) | 0 (0-11) | 0.952 | 0 (0-22) | 0 (0-22) | 0.214 |
Dry mouth | 0 (0-0) | 0 (0-0) | 0.681 | 0 (0-0) | 0 (0-0) | 0.982 |
Taste | 0 (0-0) | 0 (0-0) | 0.609 | 0 (0-0) | 0 (0-0) | 0.858 |
Body image | 0 (0-0) | 0 (0-0) | 0.573 | 0 (0-33.3) | 0 (0-0) | 0.000 |
Hair loss | 0 (0-0) | 0 (0-0) | 0.442 | 0 (0-0) | 0 (0-0) | 0.077 |
- Citation: Zhao RY, Li HH, Zhang KC, Cui H, Deng H, Gao JW, Wei B. Comparison of short-term efficacy between totally laparoscopic gastrectomy and laparoscopic assisted gastrectomy for elderly patients with gastric cancer. World J Gastrointest Surg 2022; 14(9): 950-962
- URL: https://www.wjgnet.com/1948-9366/full/v14/i9/950.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v14.i9.950